Vicarious Surgical (RBOT) Change in Account Payables (2020 - 2025)
Vicarious Surgical (RBOT) posted quarterly Change in Account Payables of $275000.0 for Q3 2025, up 587.5% year-over-year from $40000.0 in Q3 2024, and up 170.15% quarter-over-quarter from -$392000.0 in Q2 2025.
Vicarious Surgical (RBOT) Change in Account Payables (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has reported Change in Account Payables for 6 consecutive years, with $275000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Change in Account Payables rose 587.5% year-over-year to $275000.0; the TTM figure through Sep 2025 stood at -$495000.0 (down 266.67% YoY), while the FY2024 annual figure was -$96000.0, up 79.7% from the prior year.
- Change in Account Payables grew to $275000.0 in Q3 2025 per RBOT's latest filing, from -$392000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $3.7 million in Q3 2022 and bottomed at -$3.3 million in Q4 2022.
- Historically, Change in Account Payables has averaged $22684.2 across 5 years, with a median of $14000.0 in 2024.
- Annual changes were most pronounced in 2021 — Change in Account Payables jumped 6748.41% — and 2025, when it tumbled 1135.71%.
- Vicarious Surgical's Change in Account Payables stood at $937000.0 in 2021, then slumped by 447.71% to -$3.3 million in 2022, then jumped by 91.65% to -$272000.0 in 2023, then advanced by 14.34% to -$233000.0 in 2024, then soared by 218.03% to $275000.0 in 2025.
- Business Quant data shows RBOT's Change in Account Payables at $275000.0 in Q3 2025, -$392000.0 in Q2 2025, and -$145000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 71.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -200.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 4.30 Mn |
| 10 | Vicarious Surgical | 196,495.36 | -14.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 275,000.00 |
| Sep 30, 2025 | 275,000.00 |
| Jun 30, 2025 | -392,000.00 |
| Jun 30, 2025 | -392,000.00 |
| Mar 31, 2025 | -145,000.00 |
| Mar 31, 2025 | -145,000.00 |
| Dec 31, 2024 | -233,000.00 |
| Dec 31, 2024 | -233,000.00 |
| Sep 30, 2024 | 40,000.00 |
| Sep 30, 2024 | 40,000.00 |
| Jun 30, 2024 | 83,000.00 |
| Jun 30, 2024 | 83,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Dec 31, 2023 | -272,000.00 |
| Dec 31, 2023 | -272,000.00 |
| Sep 30, 2023 | -20,000.00 |
| Sep 30, 2023 | -20,000.00 |
| Jun 30, 2023 | -351,000.00 |
| Jun 30, 2023 | -351,000.00 |